theramex hq uk limited Company Information
Company Number
10944626
Website
www.theramex.comRegistered Address
5th floor 50 broadway, london, SW1H 0BL
Industry
Activities of financial services holding companies
Wholesale of pharmaceutical goods
Telephone
02039625555
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
iwh uk midco limited 100%
theramex hq uk limited Estimated Valuation
Pomanda estimates the enterprise value of THERAMEX HQ UK LIMITED at £328.8m based on a Turnover of £137.9m and 2.39x industry multiple (adjusted for size and gross margin).
theramex hq uk limited Estimated Valuation
Pomanda estimates the enterprise value of THERAMEX HQ UK LIMITED at £560m based on an EBITDA of £43.8m and a 12.77x industry multiple (adjusted for size and gross margin).
theramex hq uk limited Estimated Valuation
Pomanda estimates the enterprise value of THERAMEX HQ UK LIMITED at £0 based on Net Assets of £-319.4m and 1.85x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Theramex Hq Uk Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Theramex Hq Uk Limited Overview
Theramex Hq Uk Limited is a live company located in london, SW1H 0BL with a Companies House number of 10944626. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in September 2017, it's largest shareholder is iwh uk midco limited with a 100% stake. Theramex Hq Uk Limited is a young, mega sized company, Pomanda has estimated its turnover at £137.9m with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Theramex Hq Uk Limited Health Check
Pomanda's financial health check has awarded Theramex Hq Uk Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 5 areas for improvement. Company Health Check FAQs
7 Strong
0 Regular
5 Weak
Size
annual sales of £137.9m, make it larger than the average company (£18.1m)
£137.9m - Theramex Hq Uk Limited
£18.1m - Industry AVG
Growth
3 year (CAGR) sales growth of 4%, show it is growing at a slower rate (6.5%)
4% - Theramex Hq Uk Limited
6.5% - Industry AVG
Production
with a gross margin of 83.1%, this company has a lower cost of product (51.9%)
83.1% - Theramex Hq Uk Limited
51.9% - Industry AVG
Profitability
an operating margin of 10.1% make it more profitable than the average company (7.5%)
10.1% - Theramex Hq Uk Limited
7.5% - Industry AVG
Employees
with 96 employees, this is above the industry average (50)
96 - Theramex Hq Uk Limited
50 - Industry AVG
Pay Structure
on an average salary of £256.2k, the company has a higher pay structure (£77k)
£256.2k - Theramex Hq Uk Limited
£77k - Industry AVG
Efficiency
resulting in sales per employee of £1.4m, this is more efficient (£420.4k)
£1.4m - Theramex Hq Uk Limited
£420.4k - Industry AVG
Debtor Days
it gets paid by customers after 329 days, this is later than average (52 days)
329 days - Theramex Hq Uk Limited
52 days - Industry AVG
Creditor Days
its suppliers are paid after 65 days, this is slower than average (40 days)
65 days - Theramex Hq Uk Limited
40 days - Industry AVG
Stock Days
it holds stock equivalent to 72 days, this is more than average (45 days)
72 days - Theramex Hq Uk Limited
45 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 25 weeks, this is more cash available to meet short term requirements (20 weeks)
25 weeks - Theramex Hq Uk Limited
20 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 152.9%, this is a higher level of debt than the average (57.1%)
152.9% - Theramex Hq Uk Limited
57.1% - Industry AVG
theramex hq uk limited Credit Report and Business Information
Theramex Hq Uk Limited Competitor Analysis
Perform a competitor analysis for theramex hq uk limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
theramex hq uk limited Ownership
THERAMEX HQ UK LIMITED group structure
Theramex Hq Uk Limited has no subsidiary companies.
Ultimate parent company
CVC CAPITAL PARTNERS VI LTD
#0112828
2 parents
THERAMEX HQ UK LIMITED
10944626
theramex hq uk limited directors
Theramex Hq Uk Limited currently has 3 directors. The longest serving directors include Mr Matthew Frankel (Feb 2019) and Mr Pierre Winand (Jan 2020).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Matthew Frankel | United Kingdom | 56 years | Feb 2019 | - | Director |
Mr Pierre Winand | United Kingdom | 58 years | Jan 2020 | - | Director |
Mr Robert Stewart | United Kingdom | 57 years | Mar 2020 | - | Director |
THERAMEX HQ UK LIMITED financials
Theramex Hq Uk Limited's latest turnover from December 2022 is £137.9 million and the company has net assets of -£319.4 million. According to their latest financial statements, Theramex Hq Uk Limited has 96 employees and maintains cash reserves of £23.4 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
---|---|---|---|---|---|
Turnover | 137,873,648 | 110,745,132 | 142,538,261 | 123,250,991 | 166,693,101 |
Other Income Or Grants | 0 | 0 | 0 | 0 | 0 |
Cost Of Sales | 23,305,063 | 13,749,892 | 44,712,174 | 38,039,794 | 79,803,507 |
Gross Profit | 114,568,585 | 96,995,240 | 97,826,087 | 85,211,196 | 86,889,594 |
Admin Expenses | 100,611,856 | 77,547,382 | 88,295,652 | 93,746,733 | 114,131,642 |
Operating Profit | 13,956,729 | 19,447,858 | 9,530,435 | -8,535,537 | -27,242,048 |
Interest Payable | 74,701,861 | 81,627,867 | 73,462,609 | 57,204,283 | 30,962,199 |
Interest Receivable | 338,381 | 205,106 | 0 | 0 | 0 |
Pre-Tax Profit | -60,406,750 | -61,974,903 | -63,932,174 | -65,739,820 | -75,826,945 |
Tax | -1,731 | 77,888 | 0 | 0 | 3,538,638 |
Profit After Tax | -60,408,481 | -61,897,014 | -63,932,174 | -65,739,820 | -72,288,307 |
Dividends Paid | 0 | 0 | 0 | 0 | 0 |
Retained Profit | -60,408,481 | -61,897,014 | -63,932,174 | -65,739,820 | -72,288,307 |
Employee Costs | 24,599,740 | 33,572,479 | 16,893,913 | 11,604,418 | 6,781,214 |
Number Of Employees | 96 | 96 | 85 | 66 | 31 |
EBITDA* | 43,834,703 | 47,290,350 | 10,040,000 | 15,200,236 | -6,612,037 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
---|---|---|---|---|---|
Tangible Assets | 16,900,043 | 14,757,248 | 11,860,870 | 7,953,798 | 4,267,336 |
Intangible Assets | 438,630,896 | 465,004,760 | 489,152,174 | 461,197,201 | 462,527,095 |
Investments & Other | 9,678,926 | 7,246,213 | 3,897,390 | 179,580 | 194,730 |
Debtors (Due After 1 year) | 3,475,551 | 3,475,551 | 3,492,173 | 3,385,886 | 0 |
Total Fixed Assets | 452,055,387 | 476,286,456 | 497,520,869 | 465,765,112 | 466,794,431 |
Stock & work in progress | 4,598,009 | 1,507,572 | 5,595,652 | 6,622,544 | 14,499,074 |
Trade Debtors | 124,343,574 | 406,112,505 | 21,514,783 | 25,533,260 | 20,863,512 |
Group Debtors | 0 | 0 | 417,630,434 | 188,532,164 | 34,241,783 |
Misc Debtors | 0 | 0 | 32,581,739 | 5,824,129 | 1,745,528 |
Cash | 23,395,932 | 69,030,722 | 30,076,521 | 22,356,462 | 6,505,418 |
misc current assets | 0 | 0 | 0 | 0 | 0 |
total current assets | 152,337,516 | 476,650,801 | 507,399,130 | 248,868,561 | 77,855,318 |
total assets | 604,392,903 | 952,937,257 | 1,004,919,999 | 714,633,673 | 544,649,749 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 4,150,584 | 314,822,155 | 0 | 22,731,642 | 15,610,186 |
Group/Directors Accounts | 0 | 0 | 1 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 128,948 | 0 | 333,913 | 275,693 | 0 |
other current liabilities | 43,292,080 | 0 | 819,960,869 | 169,339,009 | 37,338,972 |
total current liabilities | 47,571,614 | 314,822,155 | 820,294,783 | 192,346,345 | 52,949,159 |
loans | 0 | 231,934 | 768,852,172 | 655,458,223 | 563,202,044 |
hp & lease commitments | 0 | 115,967 | 0 | 379,394 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 |
other liabilities | 876,263,954 | 897,664,214 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 876,263,954 | 897,780,181 | 384,426,086 | 655,078,829 | 563,202,044 |
total liabilities | 923,835,568 | 1,212,602,336 | 1,204,720,869 | 847,425,174 | 616,151,203 |
net assets | -319,442,665 | -259,665,079 | -199,800,869 | -132,791,501 | -71,501,454 |
total shareholders funds | -319,442,666 | -259,665,080 | -199,800,870 | -132,791,502 | -71,501,454 |
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
---|---|---|---|---|---|
Operating Activities | |||||
Operating Profit | 13,956,729 | 19,447,858 | 9,530,435 | -8,535,537 | -27,242,048 |
Depreciation | 630,030 | 439,637 | 509,565 | 1,012,562 | 96,044 |
Amortisation | 29,247,944 | 27,402,855 | 0 | 22,723,210 | 20,533,967 |
Tax | -1,731 | 77,888 | 0 | 0 | 3,538,638 |
Stock | 3,090,437 | -4,088,080 | -1,026,892 | -7,876,530 | 14,499,074 |
Debtors | -281,768,931 | -65,631,073 | 251,943,689 | 166,424,617 | 56,850,823 |
Creditors | -310,671,571 | 314,822,155 | -22,731,642 | 7,121,456 | 15,610,186 |
Accruals and Deferred Income | 43,292,080 | -819,960,869 | 650,621,860 | 132,000,037 | 37,338,972 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | 55,131,975 | -388,051,323 | 387,013,421 | -4,226,359 | -21,474,138 |
Investing Activities | |||||
capital expenditure | |||||
Change in Investments | 2,432,713 | 3,348,823 | 3,717,810 | -15,150 | 194,730 |
cash flow from investments | |||||
Financing Activities | |||||
Bank loans | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | -1 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 |
Long term loans | -231,934 | -768,620,238 | 113,393,949 | 92,256,179 | 563,202,044 |
Hire Purchase and Lease Commitments | 12,981 | -217,946 | -321,174 | 655,087 | 0 |
other long term liabilities | -21,400,260 | 897,664,214 | 0 | 0 | 0 |
share issue | |||||
interest | -74,363,480 | -81,422,761 | -73,462,609 | -57,204,283 | -30,962,199 |
cash flow from financing | -95,351,797 | 49,436,072 | 36,532,972 | 40,156,755 | 533,026,698 |
cash and cash equivalents | |||||
cash | -45,634,790 | 38,954,201 | 7,720,059 | 15,851,044 | 6,505,418 |
overdraft | 0 | 0 | 0 | 0 | 0 |
change in cash | -45,634,790 | 38,954,201 | 7,720,059 | 15,851,044 | 6,505,418 |
P&L
December 2022turnover
137.9m
+24%
operating profit
14m
-28%
gross margin
83.1%
-5.12%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
-319.4m
+0.23%
total assets
604.4m
-0.37%
cash
23.4m
-0.66%
net assets
Total assets minus all liabilities
theramex hq uk limited company details
company number
10944626
Type
Private limited with Share Capital
industry
64205 - Activities of financial services holding companies
46460 - Wholesale of pharmaceutical goods
incorporation date
September 2017
age
7
accounts
Full Accounts
ultimate parent company
previous names
iwh uk midco 2 limited (December 2017)
incorporated
UK
address
5th floor 50 broadway, london, SW1H 0BL
last accounts submitted
December 2022
theramex hq uk limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 5 charges/mortgages relating to theramex hq uk limited. Currently there are 2 open charges and 3 have been satisfied in the past.
theramex hq uk limited Companies House Filings - See Documents
date | description | view/download |
---|